E. Meijer

E-mail:
esther.meijer umcg.nl

Research

Publications
  1. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors

    DIPAK-1 Study Investigators, Nov-2019, In : American Journal of Nephrology. 50, 5, p. 375-385 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD

    DIPAK-1 Study Investigators, Messchendorp, A. L., Kramers, B. J., Spithoven, E. M., Stade, K., Meijer, E. & Gansevoort, R. T., Aug-2019, In : Kidney International Reports. 4, 8, p. 1170-1174 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients

    DIPAK Consortium, Dekker, S. E. I., Ruhaak, L. R., Romijn, F. P. H. T. M., Meijer, E., Cobbaert, C. M., de Fijter, J. W. & Soonawala, D., Jun-2019, In : Kidney International Reports. 4, 6, p. 833-841 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Somatostatin in renal physiology and autosomal dominant polycystic kidney disease

    DIPAK Consortium Investigators, 27-Apr-2019, In : Nephrology, Dialysis, Transplantation. 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (56) »

View graph of relations

ID: 226590